Clinical Trial Update: Oxytocin to Enhance Integrated Treatment for AUD and PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating oxytocin as an adjunct to treat co-occurring PTSD and Alcohol Use Disorder; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: PTSD, Alcohol Use Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING